Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Ghisletta
PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Related publications
PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab
British Journal of Cancer
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results From CALGB 80203 (Alliance)
Clinical Cancer Research
Cancer Research
Oncology
Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients
Investigational New Drugs
Oncology
Pharmacology
Loss of Smad4 Expression Predicts Liver Metastasis in Human Colorectal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
Frontiers in Oncology
Cancer Research
Oncology
Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada
International Journal of Cancer
Cancer Research
Oncology
Cetuximab Retreatment in Patients With Metastatic Colorectal Cancer Who Exhibited a Clinical Benefit in Response to Prior Cetuximab: A Retrospective Study
Oncology Letters
Cancer Research
Oncology